|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-4-18
|
|
pubmed:abstractText |
Screening and prophylactic treatment for hepatitis B virus (HBV) reactivation is recommended for patients who receive immunosuppressive or cytotoxic therapy. The aim of this study was to clarify the prevalence of HBV reactivation in rheumatoid arthritis (RA) patients who had received more than 1 year of immunosuppressive therapy. This study also evaluated guidelines for determining HBV reactivation in patients with RA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1435-5922
|
|
pubmed:author |
pubmed-author:EnomotoMasaruM,
pubmed-author:GotoHitoshiH,
pubmed-author:HinoMasayukiM,
pubmed-author:InabaMasaakiM,
pubmed-author:KawadaNorifumiN,
pubmed-author:KoikeTatsuyaT,
pubmed-author:MorikawaHiroyasuH,
pubmed-author:NakataniTatsuyaT,
pubmed-author:TadaMasahiroM,
pubmed-author:TamoriAkihiroA,
pubmed-author:WakitaniShigeyukiS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
556-64
|
|
pubmed:meshHeading |
pubmed-meshheading:21246383-Antirheumatic Agents,
pubmed-meshheading:21246383-Antiviral Agents,
pubmed-meshheading:21246383-Arthritis, Rheumatoid,
pubmed-meshheading:21246383-DNA, Viral,
pubmed-meshheading:21246383-Female,
pubmed-meshheading:21246383-Follow-Up Studies,
pubmed-meshheading:21246383-Guanine,
pubmed-meshheading:21246383-Hepatitis B,
pubmed-meshheading:21246383-Hepatitis B Core Antigens,
pubmed-meshheading:21246383-Hepatitis B virus,
pubmed-meshheading:21246383-Humans,
pubmed-meshheading:21246383-Immunosuppressive Agents,
pubmed-meshheading:21246383-Liver Failure,
pubmed-meshheading:21246383-Male,
pubmed-meshheading:21246383-Mass Screening,
pubmed-meshheading:21246383-Middle Aged,
pubmed-meshheading:21246383-Polymerase Chain Reaction,
pubmed-meshheading:21246383-Practice Guidelines as Topic,
pubmed-meshheading:21246383-Prospective Studies,
pubmed-meshheading:21246383-Time Factors,
pubmed-meshheading:21246383-Tumor Necrosis Factor-alpha,
pubmed-meshheading:21246383-Virus Activation
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
|
|
pubmed:affiliation |
Department of Hepatology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. atamori@med.osaka-cu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
